Learning patterns of HIV-1 resistance to broadly neutralizing antibodies with reduced subtype bias using multi-task learning
Igiraneza AB. et al, (2024), PLOS Computational Biology, 20, e1012618 - e1012618
Drivers of epidemic dynamics in real time from daily digital COVID-19 measurements.
Kendall M. et al, (2024), Science (New York, N.Y.)
Estimating the contribution of setting-specific contacts to SARS-CoV-2 transmission using digital contact tracing data.
Wang Z. et al, (2024), Nature communications, 15
Prevalence of persistent SARS-CoV-2 in a large community surveillance study.
Ghafari M. et al, (2024), Nature
Digital measurement of SARS-CoV-2 transmission risk from 7 million contacts
Ferretti L. et al, (2024), Nature, 626, 145 - 150
Demographics of sources of HIV-1 transmission in Zambia: a molecular epidemiology analysis in the HPTN 071 PopART study.
Hall M. et al, (2023), The Lancet. Microbe
Longitudinal population-level HIV epidemiologic and genomic surveillance highlights growing gender disparity of HIV transmission in Uganda.
Monod M. et al, (2023), Nature microbiology
Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1
Tsui JL-H. et al, (2023), Science, 381, 336 - 343
Uptake of medical male circumcision with household-based testing, and the association of traditional male circumcision and HIV infection
Zewdie K. et al, (2023), AIDS, 37, 795 - 802
Growing gender disparity in HIV infection in Africa: sources and policy implications
Ratmann O. et al, (2023)
Frequency matters: comparison of drug resistance mutation detection by Sanger and next-generation sequencing in HIV-1
Balakrishna S. et al, (2023), Journal of Antimicrobial Chemotherapy, 78, 656 - 664
How to avoid a local epidemic becoming a global pandemic.
Stenseth NC. et al, (2023), Proceedings of the National Academy of Sciences of the United States of America, 120
Large-scale calibration and simulation of COVID-19 epidemiologic scenarios to support healthcare planning
Groves-Kirkby N. et al, (2023), Epidemics, 42, 100662 - 100662
Epidemiological impacts of the NHS COVID-19 app in England and Wales throughout its first year
Kendall M. et al, (2023), Nature Communications, 14
The mutational spectrum of SARS-CoV-2 genomic and antigenomic RNA
Zhao L. et al, (2022), Proceedings of the Royal Society B: Biological Sciences, 289
Slowly declining growth rates and dynamic reporting delays characterise the Monkeypox epidemic in the UK over May-August 2022
Panovska-Griffiths J. et al, (2022)
Projected outcomes of universal testing and treatment in a generalised HIV epidemic in Zambia and South Africa (the HPTN 071 [PopART] trial): a modelling study.
Probert WJM. et al, (2022), The lancet. HIV, 9, e771 - e780
Epidemiological dynamics of bacteriocin competition and antibiotic resistance
Lehtinen S. et al, (2022), Proceedings of the Royal Society B: Biological Sciences, 289
Estimating SARS-CoV-2 variant fitness and the impact of interventions in England using statistical and geo-spatial agent-based models
Hinch R. et al, (2022), Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 380
Statistical and agent-based modelling of the transmissibility of different SARS-CoV-2 variants in England and impact of different interventions
Panovska-Griffiths J. et al, (2022), Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 380
Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
Willett BJ. et al, (2022), Nature Microbiology, 7, 1709 - 1709
EpiBeds: Data informed modelling of the COVID-19 hospital burden in England
Overton CE. et al, (2022), PLOS Computational Biology, 18, e1010406 - e1010406
Estimating the potential to prevent locally acquired HIV infections in a UNAIDS Fast-Track City, Amsterdam
Blenkinsop A. et al, (2022), eLife, 11
HIV drug resistance in a community‐randomized trial of universal testing and treatment: HPTN 071 (PopART)
Fogel JM. et al, (2022), Journal of the International AIDS Society, 25
Improving Post-Release Care Engagement for People Living with HIV Involved in the Criminal Justice System: A Systematic Review
Moher M. et al, (2022), AIDS and Behavior, 26, 1607 - 1617
Human Immunodeficiency Virus (HIV) Genetic Diversity Informs Stage of HIV-1 Infection Among Patients Receiving Antiretroviral Therapy in Botswana
Ragonnet-Cronin M. et al, (2022), The Journal of Infectious Diseases, 225, 1330 - 1338
Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load
Zhao L. et al, (2022), Virus Evolution, 8
A highly virulent variant of HIV-1 circulating in the Netherlands
Wymant C. et al, (2022), Science, 375, 540 - 545
Statistical and agent-based modelling of the transmissibility of different SARS-CoV-2 variants in England and impact of different interventions
Panovska-Griffiths J. et al, (2022)
A rapid, integrated method to monitor HIV viral load, drug resistance, and transmission patterns from finger-prick blood samples
Chaudron SE. et al, (2022), JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 25, 19 - 20
Depressive symptoms and HIV risk behaviours among adolescents enrolled in the HPTN071 (PopART) trial in Zambia and South Africa.
Shanaube K. et al, (2022), PloS one, 17
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Twohig KA. et al, (2022), The Lancet Infectious Diseases, 22, 35 - 42
Many but small HIV-1 non-B transmission chains in the Netherlands
Bezemer D. et al, (2022), AIDS, 36, 83 - 94
Publisher Correction: Monitoring key epidemiological parameters of SARS-CoV-2 transmission
Kraemer MUG. et al, (2022), Nature Medicine, 28, 213 - 213
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.
Elliott P. et al, (2021), Science (New York, N.Y.), 374
Monitoring key epidemiological parameters of SARS-CoV-2 transmission
Kraemer MUG. et al, (2021), Nature Medicine, 27, 1854 - 1855
The impact of viral mutations on recognition by SARS-CoV-2 specific T cells
de Silva TI. et al, (2021), iScience, 24, 103353 - 103353
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
Clemens SAC. et al, (2021), Nature Communications, 12